Skip to content

Contact +44 (0) 20 7060 7474 email us

Prescription Drugs

Anesthesia Drugs

Worldwide Markets

Publication Date July 2007
Publisher Kalorama Information
Product Type Report
Pages 156
ISBN Number not applicable
Product Code KAL00114

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

print £2,240 ($3,392 | €2,500)

Buy Now

Order above formats by FAX

Order by Fax

Summary

The number of procedures requiring anesthetic administration continues to climb with the growing and aging population in many regions of the world. The population of the world plays an important role in the growing incidence and prevalence of disease and will reflect positively on growth for anesthesia drugs.

This Kalorama Information report - Anesthesia Drugs: Worldwide Markets - focuses on three primary segments of anesthesia:

  • General Anesthesia (Inhalation, Parenteral and Rectal)
  • Local Anesthesia (Parenteral
  • Adjunctive Therapies in Anesthesia

The report covers both currently marketed and late stage development anesthesia drugs in detail. Revenues for each segment were generated using dollar and unit sales for each product.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information. Statistical information is presented as a worldwide overview, with special emphasis on the U.S. The market segments provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers. The report also includes current issues and trends affecting the industry.

The issues and trends addressed in the anesthesia drug market include:

  • Regulation of Anesthesia Drugs
  • Dentistry and Anesthesia
  • Anesthesia and Pediatric Applications
  • Anesthesia and Benefits to Depressed Patients
  • Anesthesia and Sleep
  • Gender Differences in Anesthesia Reaction
  • Trends in Conscious Sedation

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study

Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The base year for data was 2006. Historical data is provided for the years 2004 and 2005, with forecast data provided for 2007 through 2011. Compound annual growth rates (CAGRs) are provided for the 2004-2006, 2006-2011 and 2004-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006 with a projected competitive analysis for 2011.

The forecasted market analysis for 2007-2011 is based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

Contents

  • Chapter One: Executive Summary
    • Introduction
    • Scope and Methodology
    • Size and Growth of the Market
    • Issues and Trends Affecting Market
    • Leading Competitors
  • Chapter Two: Introduction The World Anesthesia
    • Drug Market
    • Introduction and History to Anesthesia Drugs
    • Types of Anesthesia
    • General Anesthesia
    • Local Anesthesia
    • Adjunctive Therapies in Anesthesia
    • Routes of Administration
    • Inhalation
    • Mask Inhalation
    • Laryngeal Mask
    • Endotracheal Administration
    • Controlled Respiration
    • Intravenous
    • Topical Application
    • Transdermal/Transmucosal Application
    • Distribution Channels
    • Demographics and Statistics
    • Worldwide Demographics
    • Procedures by Type
    • Complications in Anesthesia
  • Chapter Three: General Anesthesia
    • Overview
    • Induction of General Anesthesia
    • Preoxygenation
    • Loss of Consciousness
    • Description of Products
    • Diprivan
    • Ultane/Sevorane
    • Ethrane
    • Forane
    • Pentothal
    • Suprane
    • Ketalar
    • Brevital
    • Generic Drug Impact and Availability
    • Research and Development
    • Aquavan
    • Propofol IDD-D
    • Market Size and Growth
    • Competitive Analysis
  • Chapter Four: Local Anesthesia
    • Overview
    • Techniques of Administration
    • Topical Application
    • Transdermal/Transmucosal
    • Simple Local Infiltration
    • Regional Injections
    • Spinal and Epidural Anesthesia
    • Intrathecal Block
    • Epidural, Peridural Block
    • Description of Products
    • AminoAmides
    • Xylocaine/LidoSite/Lidoderm/Dentipatch
    • Carbocaine/Isocaine/Polocaine
    • Marcaine/Sensorcaine
    • Citanest
    • Naropin
    • Septocaine
    • Amino Esters
    • Novocaine
    • Cetacaine/Pontocaine
    • Nesacaine
    • Cocaine Hydrochloride
    • Strocain /Mucaine
    • Combinations
    • Synera/Pliaglis
    • EMLA
    • Duocaine
    • Exactacain
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
    • Competitive Analysis
  • Chapter Five: Adjunctive Therapies in Anesthesia
    • Overview
    • Description of Products
    • Neuromuscular Blocking Agents
    • Preanesthetic Sedation and Anesthesia Maintenance
    • Anesthesia Reversal Agents
    • Generic Drug Impact and Availability
    • Research and Development
    • Market Size and Growth
    • Competitive Analysis
  • Chapter Six: Anesthesia Drugs: Total Market Size and Forecast
    • Total Market Size and Forecast
    • Competitor Analysis
  • Chapter Seven: Issues and Trends
    • Anesthesia Drug Market
    • Introduction
    • Regulation of Anesthesia Drugs
    • Dentistry and Anesthesia
    • Anesthesia and Complications in Pediatric Applications
    • Anesthesia and the Benefits to Depression Patients
    • Anesthesia and Sleep
    • Gender Differences in Anesthesia Reaction
    • Trends in Conscious Sedation
  • Chapter Eight: Corporate Profiles
    • Introduction
    • Abbott Laboratories
    • Abraxis BioScience, Inc
    • Anesiva, Inc.
    • Baxter International, Inc.
    • B. Braun Melsungen AG
    • Dentsply International, Inc.
    • Endo Pharmaceuticals Holdings, Inc
    • Hospira, Inc.
    • MGI Pharma, Inc.
    • Minrad International, Inc.
    • Organon N.V.
    • Roche.
    • SkyePharma plc
    • TEVA
  • Appendix: Anesthesia List of Companies

Table Of Exhibits

  • Chapter One: Executive Summary
    • Table 1-1: The Market for Anesthesia Drugs 2004-2011
    • Figure 1-1: The Market for Anesthesia Drugs 2004-2011
  • Chapter Two: Introduction: The World Anesthesia Drug Market
    • Table 2-1: World Population by Selected Geographical Region, 2006-2050
    • Figure 2-1: World Population by Selected Geographical Region, 2006-2050
    • Table 2-2: Estimated World Population by Age and Geographical Region, 2006
    • Table 2-2: Estimated World Population by Age and Geographical Region, 2006
    • Table 2-3: Procedures by Type, 2006
    • Figure 2-3: Procedures by Type Worldwide, 2006
    • Figure 2-4: Procedures by Type U.S., 2006
    • Table 2-4: Worldwide Anesthesia Complications and Related Mortality
    • Figure 2-5: Worldwide Anesthesia Complications and Related Mortality
  • Chapter Three: General Anesthesia
    • Table 3-1: Marketed Brands for General Anesthesia Drugs (Type, Brand, and Manufacturer)
    • Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia
    • Figure 3-1: Brand vs. Generic General Anesthetic Market 2004-2006
    • Table 3-3: General Anesthesia Drugs in Development
    • Table 3-4: The Market for General Anesthesia Drugs 2004-2011
    • Figure 3-2: The Market for General Anesthesia Drugs 2004-2011
    • Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Inhalation, Parenteral and Rectal, Total)
    • Figure 3-3: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2006 (Inhalation, Parenteral and Rectal, Total)
    • Table 3-6: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Figure 3-4: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Table 3-7: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
    • Figure 3-5: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006
  • Chapter Four: Local Anesthesia
    • Table 4-1: Selected Marketed Local Anesthesia Drugs (Type, Brand, and Manufacturer)
    • Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia
    • Figure 4-1: Brand vs. Generic Local Anesthetic Market 2004-2006
    • Table 4-3: Local Anesthesia Drugs in Development
    • Table 4-4: The Market for Local Anesthesia Drugs 2004-2011
    • Figure 4-2: The Market for Local Anesthesia Drugs 2004-2011
    • Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Delivery Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
    • Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2006 (Topical, Transdermal/Transmucosal, Parenteral)
    • Table 4-6: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Table 4-7: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2006
    • Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by Leading Suppliers 2006
  • Chapter Five: Adjunctive Therapies in Anesthesia
    • Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia (Type, Brand, and Manufacturer)
    • Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia
    • Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2004-2006
    • Table 5-3: Adjunctive Therapies in Anesthesia in Development
    • Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2004-2011
    • Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2004-2011
    • Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2006 (U.S., E.U., Rest of World)
    • Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2006
    • Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2006